'Regulatory institutions' diaporamas de présentation

Presentation

297 views • 21 slides

Presentation

214 views • 21 slides

Rethinking Development

Rethinking Development. Joseph E. Stiglitz Bangalore January 2013. Brief review of development thinking. From projects to policies The failure of the Washington Consensus policies They were predicated on the notion that markets by themselves were efficient and stable,

340 views • 20 slides

EU Infrastructure Trust Fund

EU Infrastructure Trust Fund. The EU - Africa Partnership on Infrastructure and the Trust Fund. Antonio Garcia Fragio Head of Division Transport, Energy, Water, ICT and urban development Directorate General Development European Commission. Addis Abeba 19 June 2006. Outline.

435 views • 19 slides

by Vidmantas Jankauskas Chairman ERRA

337 views • 18 slides

NATIONAL AND COMMUNITY MENTAL HEALTH PROGRAMME

NATIONAL AND COMMUNITY MENTAL HEALTH PROGRAMME. AIMS OF NCMHP. To ensure treatment and prevention of mental and neurological disorder. Use of mental health technology Application of mental health principles in total national development to improve quality of life. OBJECTIVES.

1.03k views • 17 slides

Green Paper for Post-School Education & Training FP & M Seta Board Presentation March 2012

Green Paper for Post-School Education & Training FP & M Seta Board Presentation March 2012. Presentation Map. Introduction Challenges with current system Vision Proposals Co nclusion. Introduction. This Green Paper is meant to;

304 views • 16 slides

The Future of Targeted Drug Delivery

The Future of Targeted Drug Delivery. Lisa Shafer, PhD. Director, CNS Drug Therapy R&D Medtronic Neuromodulation lisa.l.shafer@medtronic.com. DISCLAIMERS This presentation includes the description of devices and therapeutic uses that are in early stages of development.

885 views • 15 slides

Pharmaceuticals

Pharmaceuticals. Econ 737 4 /7/11. Outline. I. Introduction II. Research and development III. Regulation IV. Patents V. Pricing VI. Direct to consumer advertising. I. Introduction. Pharmaceuticals: mostly medicines and vaccines

339 views • 13 slides

Pharmaceuticals

Pharmaceuticals. Econ 737 11/11/10. Outline. I. Introduction II. Research and development III. Regulation IV. Patents V. Pricing VI. Direct to consumer advertising. I. Introduction. Pharmaceuticals: mostly medicines and vaccines

322 views • 13 slides